BamSEC and AlphaSense Join Forces
Learn More

Aclaris Therapeutics Inc. – Indentures

NASDAQ: ACRS    
Share price (3/24/26): $3.30    
Market cap (3/24/26): $398 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.1
from 10-K 3 pages Description of Aclaris Therapeutics, Inc. Capital Stock
12/34/56
EX-4.7
from S-3 18 pages Aclaris Therapeutics, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Aclaris Therapeutics, Inc. Form of Debt Securities Warrant Agreement
12/34/56
EX-4.6
from S-3 20 pages Aclaris Therapeutics, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of Aclaris Therapeutics, Inc. Form of Preferred Stock Warrant Agreement
12/34/56
EX-4.5
from S-3 20 pages Aclaris Therapeutics, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of Aclaris Therapeutics, Inc. Form of Common Stock Warrant Agreement
12/34/56
EX-4.3
from S-3 48 pages Aclaris Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [·], 20 Debt Securities
12/34/56
EX-4.1
from 10-K 3 pages Description of Aclaris Therapeutics, Inc. Capital Stock
12/34/56
EX-4.7
from S-3ASR 18 pages Aclaris Therapeutics, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Aclaris Therapeutics, Inc. Form of Debt Securities Warrant Agreement
12/34/56
EX-4.6
from S-3ASR 20 pages Aclaris Therapeutics, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of Aclaris Therapeutics, Inc. Form of Preferred Stock Warrant Agreement
12/34/56
EX-4.5
from S-3ASR 20 pages Aclaris Therapeutics, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of Aclaris Therapeutics, Inc. Form of Common Stock Warrant Agreement
12/34/56
EX-4.3
from S-3ASR 48 pages Aclaris Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [·], 20 Debt Securities
12/34/56
EX-4.2
from 10-K 3 pages ​ Description of Aclaris Therapeutics, Inc. Capital Stock
12/34/56
EX-4.8
from S-3 18 pages Aclaris Therapeutics, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Aclaris Therapeutics, Inc. Form of Debt Securities Warrant Agreement
12/34/56
EX-4.7
from S-3 20 pages Aclaris Therapeutics, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of Aclaris Therapeutics, Inc. Form of Preferred Stock Warrant Agreement
12/34/56
EX-4.6
from S-3 20 pages Aclaris Therapeutics, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of Aclaris Therapeutics, Inc. Form of Common Stock Warrant Agreement
12/34/56
EX-4.4
from S-3 48 pages Aclaris Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [·], 20 Debt Securities
12/34/56
EX-4.2
from 10-K 3 pages Description of Aclaris Therapeutics, Inc. Capital Stock
12/34/56
EX-4.8
from S-3 21 pages Aclaris Therapeutics, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Aclaris Therapeutics, Inc. Form of Debt Securities Warrant Agreement
12/34/56
EX-4.7
from S-3 24 pages Aclaris Therapeutics, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of Aclaris Therapeutics, Inc. Form of Preferred Stock Warrant Agreement
12/34/56
EX-4.6
from S-3 23 pages Aclaris Therapeutics, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of Aclaris Therapeutics, Inc. Form of Common Stock Warrant Agreement
12/34/56
EX-4.4
from S-3 54 pages Aclaris Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [·], 20 Debt Securities
12/34/56